MetLife Investment Management’s Neogen NEOG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Buy |
119,780
+5,922
| +5% | +$58.3K | 0.01% | 1345 |
|
|
2025
Q4 | $796K | Sell |
113,858
-15,322
| -12% | -$96.4K | ﹤0.01% | 1558 |
|
|
2025
Q3 | $738K | Sell |
129,180
-2,150
| -2% | -$11.5K | ﹤0.01% | 1618 |
|
|
2025
Q2 | $628K | Hold |
131,330
| – | – | ﹤0.01% | 1572 |
|
|
2025
Q1 | $1.14M | Sell |
131,330
-109,806
| -46% | -$1.15M | 0.01% | 1296 |
|
|
2024
Q4 | $2.93M | Buy |
241,136
+17,499
| +8% | +$245K | 0.02% | 853 |
|
|
2024
Q3 | $3.76M | Sell |
223,637
-1,803
| -0.8% | -$29.7K | 0.02% | 687 |
|
|
2024
Q2 | $3.52M | Buy |
225,440
+9,054
| +4% | +$126K | 0.02% | 683 |
|
|
2024
Q1 | $3.41M | Sell |
216,386
-5,714
| -3% | -$95.7K | 0.02% | 707 |
|
|
2023
Q4 | $4.47M | Sell |
222,100
-1,710
| -0.8% | -$28.9K | 0.03% | 529 |
|
|
2023
Q3 | $4.15M | Sell |
223,810
-16,423
| -7% | -$358K | 0.03% | 517 |
|
|
2023
Q2 | $5.23M | Sell |
240,233
-1,524
| -0.6% | -$27.6K | 0.04% | 414 |
|
|
2023
Q1 | $4.48M | Sell |
241,757
-3,529
| -1% | -$66.3K | 0.03% | 510 |
|
|
2022
Q4 | $3.74M | Buy |
245,286
+52,234
| +27% | +$744K | 0.03% | 606 |
|
|
2022
Q3 | $2.7M | Buy |
193,052
+69,468
| +56% | +$1.4M | 0.02% | 743 |
|
|
2022
Q2 | $2.98M | Sell |
123,584
-3,668
| -3% | -$98.4K | 0.02% | 728 |
|
|
2022
Q1 | $3.92M | Buy |
127,252
+36,709
| +41% | +$1.32M | 0.03% | 674 |
|
|
2021
Q4 | $4.11M | Buy |
90,543
+460
| +0.5% | +$19.7K | 0.03% | 496 |
|
|
2021
Q3 | $3.91M | Sell |
90,083
-2,033
| -2% | -$88.4K | 0.04% | 491 |
|
|
2021
Q2 | $4.24M | Sell |
92,116
-4,358
| -5% | -$201K | 0.04% | 475 |
|
|
2021
Q1 | $4.29M | Sell |
96,474
-5,694
| -6% | -$239K | 0.04% | 469 |
|
|
2020
Q4 | $4.05M | Buy |
102,168
+58,050
| +132% | +$2.16M | 0.04% | 450 |
|
|
2020
Q3 | $1.73M | Sell |
44,118
-2,348
| -5% | -$89.9K | 0.02% | 781 |
|
|
2020
Q2 | $1.8M | Buy |
46,466
+3,318
| +8% | +$112K | 0.02% | 761 |
|
|
2020
Q1 | $1.45M | Hold |
43,148
| – | – | 0.02% | 744 |
|
|
2019
Q4 | $1.41M | Sell |
43,148
-2,818
| -6% | -$92.7K | 0.01% | 945 |
|
|
2019
Q3 | $1.57M | Hold |
45,966
| – | – | 0.02% | 877 |
|
|
2019
Q2 | $1.43M | Buy |
45,966
+2,446
| +6% | +$72.1K | 0.02% | 952 |
|
|
2019
Q1 | $1.25M | Hold |
43,520
| – | – | 0.01% | 990 |
|
|
2018
Q4 | $1.24M | Hold |
43,520
| – | – | 0.02% | 946 |
|
|
2018
Q3 | $1.56M | Sell |
43,520
-2,438
| -5% | -$104K | 0.02% | 956 |
|
|
2018
Q2 | $1.84M | Buy |
45,958
+1,722
| +4% | +$63.5K | 0.02% | 815 |
|
|
2018
Q1 | $1.48M | Sell |
44,236
-3,305
| -7% | -$99.6K | 0.02% | 869 |
|
|
2017
Q4 | $1.47M | Buy |
+47,541
| New | +$1.44M | 0.02% | 877 |
|
Other funds holding NEOG
VPM
VCM
IG
MetLife Investment Management's NEOG Position: Q1 2026 in Review
MetLife Investment Management increased its Neogen (NEOG) stake by 5.2% in Q1 2026, buying an estimated $58.3K and bringing the position to 119,780 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #1345.
MetLife Investment Management first reported a position in NEOG in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.23M in Q2 2023. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.
- MetLife Investment Management held 119,780 shares of Neogen worth $1.11M as of Q1 2026.
- MetLife Investment Management bought 5,922 Neogen shares in Q1 2026, an estimated $58.3K.
- Neogen made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1345 holding.
- MetLife Investment Management first reported a position in Neogen in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Neogen position peaked at $5.23M in Q2 2023.
- 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.